Can Depakote (valproate) cause urinary retention?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Depakote Cause Urinary Retention?

Depakote (valproate) is not a recognized cause of urinary retention and does not appear in established lists of medications that impair bladder function. The available evidence does not support a direct causal relationship between valproate and urinary retention.

Evidence Against Valproate as a Cause

  • Anticholinergic medications (antipsychotics, tricyclic antidepressants, antimuscarinics), alpha-adrenergic agonists, and opioids are the well-established medication classes that cause urinary retention, according to multiple guideline sources 1, 2, 3.

  • A comprehensive systematic review examining drug-induced urinary retention specifically identified antipsychotics, antidepressants, anticholinergic respiratory agents, opioids, benzodiazepines, NSAIDs, and calcium channel antagonists as causative agents—but did not include antiepileptic drugs like valproate 2.

  • The AASLD guidance on critically ill patients explicitly recommends avoiding "medications that can cause urinary retention, such as anticholinergics" in persons over 65 years, without mentioning antiepileptic medications 4.

Valproate's Actual Urinary Effects

  • A case-control study of 2,201 patients with epilepsy found that valproate was associated with an increased risk of urinary tract infections (UTI), not urinary retention 5.

  • The mechanism for UTI risk with valproate appears related to immunological and hematological side effects rather than direct effects on bladder function 5.

Clinical Approach When Urinary Retention Occurs

If a patient on valproate develops urinary retention, the evaluation should focus on:

  • Review all concomitant medications for anticholinergic agents (antipsychotics, tricyclic antidepressants), alpha-agonists, antimuscarinics, or opioids 1.

  • Assess for benign prostatic hyperplasia in men or anatomical causes in all patients 1.

  • Consider neurological causes related to the underlying seizure disorder itself rather than the antiepileptic medication 1.

  • Measure post-void residual to confirm retention 1.

Important Caveat

Elderly patients are at substantially higher risk for drug-induced urinary retention due to age-related bladder dysfunction and benign prostatic hyperplasia, particularly when using multiple medications 2. In this population, even medications not typically associated with urinary retention may contribute when combined with other risk factors.

References

Guideline

Urinary Retention Associated with Medications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.